Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Enliven Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Agios Pharmaceuticals Inc. June 18, 202687.1%
-
Enliven Therapeutics Inc. June 24, 202598.8%
-
Agios Pharmaceuticals Inc. June 13, 202396.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | Agios Pharmaceuticals Inc. | Option exercise | +2,816 | — | — |
| Aug 11, 2025 | Agios Pharmaceuticals Inc. | Option exercise | +2,302 | — | — |
| Jun 20, 2025 | Agios Pharmaceuticals Inc. | Option exercise | +2,120 | — | — |
| Nov 8, 2024 | Agios Pharmaceuticals Inc. | Option exercise | +10,000 | $25.99 | $259,900 |
| Nov 8, 2024 | Agios Pharmaceuticals Inc. | Open-market sale | −3,571 | $57.24 | $204,404 |
| Nov 8, 2024 | Agios Pharmaceuticals Inc. | Open-market sale | −4,929 | $58.57 | $288,692 |
| Nov 8, 2024 | Agios Pharmaceuticals Inc. | Open-market sale | −1,500 | $59.21 | $88,815 |
| Nov 7, 2024 | Agios Pharmaceuticals Inc. | Option exercise | +10,000 | $25.99 | $259,900 |
| Nov 7, 2024 | Agios Pharmaceuticals Inc. | Open-market sale | −8,132 | $53.32 | $433,598 |
| Nov 7, 2024 | Agios Pharmaceuticals Inc. | Open-market sale | −1,868 | $54.41 | $101,638 |
| Oct 8, 2024 | Enliven Therapeutics Inc. | Option exercise | +6,314 | $19.68 | $124,260 |
| Oct 8, 2024 | Enliven Therapeutics Inc. | Option exercise | +4,106 | $5.52 | $22,665 |
| Oct 8, 2024 | Enliven Therapeutics Inc. | Open-market sale | −10,420 | $28.17 | $293,531 |
| Aug 11, 2024 | Agios Pharmaceuticals Inc. | Option exercise | +2,302 | — | — |
| Jun 13, 2024 | Agios Pharmaceuticals Inc. | Option exercise | +3,388 | — | — |
Questions about Rahul D. Ballal
What boards is Rahul D. Ballal on?
Rahul D. Ballal sits on the boards of Agios Pharmaceuticals Inc. and Enliven Therapeutics Inc.
How long has Rahul D. Ballal served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.